Pharmaceutical

What are your pain points moving to Pharma 4.0?

Pharma 4.0 is an initiative created by the International Society for Pharmaceutical Engineering (ISPE) that aims to bring about a digital evolution within the pharmaceutical industry by implementing new technologies that increase efficiency and accuracy. Yvonne Duckworth from CRB looks into the exact ways that the industry is evolving and how to get there

Breaking News

SpectrumX creates in-house microbiology team to advance R&D

The UK-based pharmaceutical and healthcare company has hired members for the new team to further expand its product R&D division

Majority of readers prefer print

Catch up with the cleanroom industry in print, at your leisure

Kropman Contamination Control reports record CIP skid order

Kropman Contamination Control has received an order for 16 clean in place skids, which are systems that allow the CIP process to be easily transpor...

Q&A: Halyard R&D Director talks cleanroom gloves for different sectors

Halyard Health's Siew Hoe Tan discusses the different considerations, requirements and advancements used when manufacturing gloves for semiconducto...

Vaksindo chooses Intraco to build new GMP facility

Vietnam-based Intraco has provided an update on the progression of the new build, that is in the processing of reviewing HVAC and compressed air sy...

Comecer completes FAT for key therapeutic radiopharmaceutical

TerraPower chose Comecer for the factory acceptance test for their groundbreaking technology to make possible a stable supply of the Actinium-225 t...

What are your pain points moving to Pharma 4.0?

Pharma 4.0 is an initiative created by the International Society for Pharmaceutical Engineering (ISPE) that aims to bring about a digital evolution...

Interview with PathogenDx founder Milan Patel

The microarray testing company CEO discusses setting up a company and product to penetrate the microbiology testing market. The entrepreneur also d...

AM Technical Solutions announces support for downstream purification

The high-profile project is expected to require 12-18 months to complete

Study finds $1 per reaction LAMP assay works for BCC testing

The novel assay has been assessed for detecting the bacteria responsible for many pharmaceutical product recalls, Burkholderia cepacia complex

Meeting large-scale HPAPI production needs

A recent expansion at Olon’s Rodano site will enable the company to produce highly potent APIs in large-scale product batches ranging from 30-150 kg

Regulatory warning letters in pharma: What can we learn post-COVID?

A look at how the COVID-19 pandemic impacted FDA inspections and the trends that have now cropped up reflecting industry changes. Mirna Vazquez and...

Laboratory-as-a-Service expert SmartLabs chooses Boston location

The cGMP design & build expert has chosen the new Drexel and Gattuso's Life Science Research Lab Facility for its first facility in the city

Understanding cleanroom behaviours in compounding pharmacies

Protecting patients from poor-quality compounded drugs is a fundamental part of the US Food and Drug Administration’s (FDA) drug compounding progra...

CorMedix sees NDA approval delay due to CMO and API supplier issue

A Complete Response Letter (CRL) was received from the FDA stating that the DefenCath NDA cannot be approved until deficiencies recently conveyed t...

A guide to dust control in the pharmaceutical sector

The dangers of dust in any workplace environment are well documented. From a business point of view, dust can impact productivity and product quali...